Functional significance of a C–>A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

Cited by (749)

Items 501–600 of 749

1. Inefficacité de la clozapine en rapport avec un métabolisme augmenté et intérêt de la fluvoxamine : à propos de quatre cas
   F. Papetti, V. Morel-Pingault, V. Buisse, Lucile Mazière, Mikael Banayan, S Thauby, T. Besnard, GUY DARCOURT, D. Pringuey · 2007 · L Encéphale
2. Coffee, Genetic Variants, and Parkinson's Disease: Gene–Environment Interactions
   Naomi Yamada-Fowler, Peter Söderkvist · 2015 · Journal of Caffeine Research
3. The roles of caffeine and corticosteroids in modulating cortical excitability after paired associative stimulation (PAS) and transcranial alternating current stimulation (tACS) in caffeine-naïve and caffeine-adapted subjects
   Mohd Faizal Mohd Zulkifly, Ornela Merkohitaj, Walter Paulus, Jürgen Brockmöller · 2021 · Psychoneuroendocrinology
4. Enzyme polymorphisms influencing the metabolism of heterocyclic aromatic amines
   Luisa Airoldi, Cinzia Magagnotti, Roberta Pastorelli, Roberto Fanelli · 2003 · Journal of Chromatography B
5. Coffee, Myocardial Infarction, and CYP Nomenclature
   Magnus Ingelman‐Sundberg, Sarah C. Sim, Daniel W. Nebert · 2006 · JAMA
6. Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions
   Yanrong Ma, Jing Mu, Xueyan Gou, Xinan Wu · 2025 · Precision Clinical Medicine
7. Alterations in Xenobiotic-Metabolizing Enzyme Activities across Menstrual Cycle in Healthy Volunteers
   E. Asprodini, Vassiliki Tsiokou, Elias Begas, Thomas V. Kilindris, Evangelos Kouvaras, Μαρία Σαμαρά, IE Messinis · 2018 · Journal of Pharmacology and Experimental Therapeutics
8. Genetic polymorphisms in promoter and intronic regions of CYP1A2 gene in Roma and Hungarian population samples
   Renáta Szalai, Lili Magyari, Petra Mátyás, Balázs Duga, Zsolt Bánfai, András Szabó, Erzsébet Kövesdi, Béla Melegh · 2014 · Environmental Toxicology and Pharmacology
9. Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking Subjects
   И. И. Мирошниченко, Ivan V. Pozhidaev, Svetlana А. Ivanova, Natalia V. Baymeeva · 2019 · Therapeutic Drug Monitoring
10. Pharmacogenetics of bipolar disorder
    Hader Mansour, Martin Alda, Vishwajit Laxmikant Nimgaonkar · 2002 · Current Psychiatry Reports
11. Cytochrome P450 Pharmacogenetics
    Ai‐Ming Yu, Robert L. Haining · 2003 · Informa Healthcare eBooks
12. No Significant Association between CYP1A2 Polymorphism and Porphyria Cutanea Tarda
    O. Dereure, Patricia Aguilar‐Martinez, D. Bessis, Fran x E ois Blanc, Dominique G. Larrey, Bernard Guillot, Jean‐François Schved, Jean‐Jacques Guilhou · 2004 · Acta Dermato Venereologica
13. Using caffeine as a chemical means to induce flow states
    Niklas Reich, Michael Mannino, Steven Kotler · 2024 · Neuroscience & Biobehavioral Reviews
14. Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies—A Narrative Review
    Tudor-Florentin Capatina, Anamaria Oatu, Casandra Babasan, Simona Corina Trifu · 2025 · International Journal of Molecular Sciences
15. Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition
    Vincent Huin, David L Blum, Violette Delforge, Émeline Cailliau, Sofia Djeziri, Kathy Dujardin, Alexandre Genet, Romain Viard, Shahram Attarian, Gaëlle Bruneteau et al. · 2024 · Neurobiology of Disease
16. The Role of Xenobiotic Caffeine on Cardiovascular Health: Promises and Challenges
    R. Campagna, Arianna Vignini · 2025 · Journal of Xenobiotics
17. »Treatment Resistance« Enigma Resolved by Pharmacogenomics − A Case Study of Clozapine Therapy in Schizophrenia / Enigma »Terapo-Rezistence« Razrešena Uz Pomoć Farmakogenomike - Prikaz Slućaja Terapije Klozapinom U Shizofreniji
    Nadja P. Marić, Slobodanka Pejović-Nikolić, Ivana Buzadžić, Milica J. Jovicic, Sanja Andrić Petrović, Marina M. Mihaljevic, Zorana Pavlović · 2014 · Journal of Medical Biochemistry
18. Biotechnology applications in precision food
    Abubakar Siddique, Tahira Tayyaba, Muhammad Imran, Abdur Rahman · 2022 · Elsevier eBooks
19. Does “smoker’s paradox” exist in clopidogrel-treated Turkish patients with acute coronary syndrome
    Efe Edem, Ali Hikmet Kırdök, Ahmet Ozan Kınay, Ümit İlker Tekin, Sedat Taş, Erkan Alpaslan, Mustafa Türker Pabuccu, Bahri Akdeniz · 2015 · Platelets
20. Association between the CYP1A2-164 A/C polymorphism and colorectal cancer susceptibility: a meta-analysis
    Jianbing Hu, Chuan Liu, Qinghua Yin, Mingzhen Ying, Junhui Li, Lian Li, Chunxia Zhou, Yajie Wang · 2014 · Molecular Genetics and Genomics
21. Receptor pharmacogenetics: relevance to CNS syndromes
    Sanober Shaikh, Robert W Kerwin · 2002 · British Journal of Clinical Pharmacology
22. Pharmacogenetics and Antipsychotic Treatment Response/ Фармакогенетски Тестирања И Одговор Кон Третман Со Антипсихотоци
    Zorica Naumovska, Aleksandra K. Nesterovska, Ana Filipce, Zoran Sterjev, Katerina Brezovska, Aleksandar J Dimovski, Ljubica Suturkova-Milosevic · 2015 · PRILOZI
23. Metabolic susceptibility to agricultural pesticides and non-Hodgkin's lymphoma.
    Jane C. Schroeder · 2005 · PubMed
24. Cytochrome P450 1A2 Polymorphisms, Coffee Consumption and Impaired Glucose Metabolism in Japanese Men
    Michiko Kohno Osamu Tajima · 2013 · Endocrinology & Metabolic Syndrome
25. Pharmacogenetic Studies Investigating the Adverse Effects of Antipsychotics
    Heon‐Jeong Lee · 2007 · Psychiatry Investigation
26. Detection of Quantitative Trait Loci Affecting Caffeine Metabolism by Interval Mapping in a Genome-Wide Scan of C3H/HeJ × APN F2 Mice
    William L. Casley, J. Allan Menzies, Larry W. Whitehouse, Thomas W. Moon · 1999 · Drug Metabolism and Disposition
27. The Performance Effect of Scheduled Carbohydrate and Caffeine Intake during Simulated Team Sport Match-Play
    John Keane, Aidan Shovlin, Simon Devenney, Shane Malone, Damien Young, Giuseppe Coratella, Kieran D. Collins, Marcus Shortall · 2020 · Nutrients
28. Impact of CYP1A2 Genotypes on the Ergogenic Effects and Subjective Mood States of Caffeine Ingestion in Resistance-Trained Women
    Jessica M. Prather, Christine M. Florez, Amie Vargas, Bella Soto, Audrey Ross, Abby Harrison, Ariane H. Secrest, Darryn S. Willoughby, Sydney N. Kutter, Lem W. Taylor · 2024 · Nutrients
29. Influence of CYP2C19 genetic variants and smoking on dual antiplatelet efficacy in patients with coronary artery disease
    Yujing Cheng, Yan Sun, Dai Zhang, Xiaoteng Ma, Chi Liu, Chengping Hu, Tienan Sun, Ziwei Zhao, Xiaoli Liu, Yujie Zhou · 2023 · Frontiers in Cardiovascular Medicine
30. Investigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China
    Yongchao Ren, Fang Liu, Xugang Shi, Tingting Geng, Dongya Yuan, Li Wang, Longli Kang, Tianbo Jin, Chao Chen · 2017 · Molecular Medicine Reports
31. Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects
    Ken Ogasawara, Kimberly MacGorman, Liangang Liu, Jian Chen, Leonidas N. Carayannopoulos, Simon Yuji Zhou, Maria Palmisano, Yan Li · 2019 · The Journal of Clinical Pharmacology
32. Inter‐Individual Variation in Cancer and Cardiometabolic Health Outcomes in Response to Coffee Consumption: A Critical Review
    Edith Visser, Johanna Marianne Geleijnse, Baukje de Roos · 2020 · Molecular Nutrition & Food Research
33. CYP Genotypes Are Associated with Toxicity and Survival in Osteosarcoma Patients
    Alini Trujillo-Paolillo, Carolina Salinas-Souza, Indhira Dias Oliveira, Antônio Sérgio Petrilli, Sílvia Regina Caminada de Toledo · 2020 · Journal of Adolescent and Young Adult Oncology
34. Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients
    Justyna Alicja Ber, Paweł Wiczling, Marcin Hołysz, Agnieszka Klupczyńska, Alicja Bartkowska‐Śniatkowska, Krzysztof Bieda, Piotr Smuszkiewicz, Małgorzata Nowicka, Łukasz Żurański, Paweł Sobczyński et al. · 2020 · The Journal of Clinical Pharmacology
35. Five genetic polymorphisms of cytochrome P450 enzymes in the Czech non-Roma and Czech Roma population samples
    Lucie Dlouhá, Věra Adámková, Lenka Šedová, Věra Olišarová, Jaroslav Alois Hubacek, Valérie Tóthová · 2020 · Drug Metabolism and Personalized Therapy
36. Five genetic polymorphisms of cytochrome P450 enzymes in the Czech non-Roma and Czech Roma population samples
    Lucie Dlouhá, Věra Adámková, Lenka Šedová, Věra Olišarová, Jaroslav Alois Hubacek, Valérie Tóthová · 2020 · Drug metabolism and drug interactions
37. Genetics of schizophrenia: current strategies
    S Sivagnansundaram, D Müller, Alex Gubanov, Steven G. Potkin, James L. Kennedy · 2003 · Clinical Neuroscience Research
38. POLIMORFISMOS DE CITOCROMO P450: PAPEL COMO MARCADOR BIOLÓGICO
    Catalina Santiago, Félix Gómez‐Gallego · 2002
39. Human genetic variation, relationships of peoples of sub-Saharan Africa and implications for healthcare
    Naser Ansari‐Pour · 2011 · Doctoral thesis, UCL (University College London).
40. <i>CYP1A2</i> Genotype and the Ergogenic Effect of Acute Caffeine Intake on Muscular Strength and Endurance Performance in Trained Individuals
    Montalvo‐Alonso, Juan Jesús, del Val‐Manzano, Marta, Martín‐Rivas, Iván, Ferragut, Carmen, Valadés, David, Pérez‐López, Alberto · 2026 · Scandinavian Journal of Medicine &amp; Science in Sports
41. Using Bioinformatic Approaches to Identify Pathways Targeted by Human Leukemogens
    Reuben Thomas, Jimmy Phuong, Cliona M. McHale, Luoping Zhang · 2012 · International Journal of Environmental Research and Public Health
42. Association between the CYP1A2 rs762551 Polymorphism and Bladder Cancer Susceptibility: a Meta-Analysis Based on Case-Control Studies
    Yong Zeng, Huayong Jiang, Li Wei, Weidong Xu, Yajie Wang, Yadi Wang, Chuan Liu · 2015 · Asian Pacific Journal of Cancer Prevention
43. CYP1A2*1FGene Variant, Alkaline Salt Tea Intake and Risk of Esophageal Squamous Cell Carcinoma
    Idrees Ayoub Shah, Promila Mehta, Mohd Maqbool Lone, Malik Tariq Rasool, Ghulam Nabi Lone, Ghulam Mohd Gulzar, Farooq Ahmad Ganie, Mohmmad Akbar Bhat, Nazir Ahmad Dar · 2017 · Nutrition and Cancer
44. [Pharmacogenomics and the path towards personalized medicine].
    Waldo Horacio Belloso, María Ana Redal · 2010 · PubMed
45. Effects of cigarette smoking on older chinese men treated with clopidogrel monotherapy or aspirin monotherapy: a prospective study
    Yulun Cai, Weihao Xu, Hongbin Liu, Fan Wang, Lei Duan, Huiying Li, Man Li, Yuerui Li, Lina Han, Hunan Xiao · 2019 · Platelets
46. Caffeine
    Giulia Renda, Raffaele De Caterina · 2019 · Elsevier eBooks
47. CYP450 and Ethnicity
    Joseph E. McGraw · 2014 · Elsevier eBooks
48. CYP1A21*F contains the −163C>A substitution and is highly inducible
    Sarah C. Sim · 2013 · Pharmacogenetics and Genomics
49. Polymorphisms in the DGAT1 gene in buffaloes (Bubalus bubalis) in the Amazon
    C.S. Silva, Silva Filho, A.S. Matos, Alex Sandro Schierholt, Mônica Regina Farias Costa, Larissa Coêlho Marques, J.S. Costa, R.L. Sales, Marivaldo Rodrigues Figueiró, J. R. F. Marques · 2016 · Genetics and Molecular Research
50. Cytochrome P450 enzymes— in vitro , in vivo , and in silico studies
    Miia Turpeinen · 2006
51. Caffeine Consumption, Psychological Distress, and Insomnia in a Cohort of Individuals with Depression
    Harry A. McIntosh, Aleah J Borgas, Nisreen Aouira, Brittany L. Mitchell, Jacob J. Crouse, Sarah Elizabeth Medland, Ian Bernard Hickie, Naomi R. Wray, Nicholas G. Martin, Christel Maria Middeldorp et al. · 2025 · Complex Psychiatry
52. CYP1A2 genotype-dependent effects of smoking on mirtazapine serum concentrations
    Maike Scherf‐Clavel, Heike Weber, Carolin Weiß, Catherina Klüpfel, Saskia Stonawski, Leif G. Hommers, Stefan Unterecker, Katharina Domschke, Andreas Menke, Sarah Kittel‐Schneider et al. · 2025 · Journal of Psychopharmacology
53. Meta-analysis of the CYP1A2 -163C＞A Polymorphism and Lung Cancer Risk
    Shengqiong Deng, Xian‐Tao Zeng, Yun Wang, Qing Ke, Qiong-Li Xu · 2013 · Asian Pacific Journal of Cancer Prevention
54. Challenging pharmacotherapy management of a psychotic disorder due to a delicate pharmacogenetic profile and drug-drug interactions: a case report and literature review
    Andrej Belančić, Aristea Pavešić Radonja, Lana Ganoci, Dinko Vitezić, Nada Božina · 2024 · Croatian Medical Journal
55. The Highs and Lows of Caffeine Intake in New Zealand Children
    Ajmol Ali, Carol A. Wham, Fran M. Wolber, Martin Dickens, Karyn O’Keeffe, Michelle C. Thunders, Judy Thomas, Carlene S. Starck, Kay Janice Rutherfurd-Markwick · 2018 · Journal of Caffeine and Adenosine Research
56. Safety-Related Quality Issues for the Development of Herbal Drugs
    Pulok Kumar Mukherjee · 2019 · Elsevier eBooks
57. Simultaneous quantitation of serum caffeine and its metabolites by ultra‐high‐performance liquid chromatography–tandem mass spectrometry for CYP1A2 activity prediction in premature infants
    Zhouhong Jiang, Xiangbo Gao, Jianfeng Liang, Shaoqing Ni · 2021 · Biomedical Chromatography
58. Pharmacogenetics and Analgesic Effects of Antidepressants in Chronic Pain Management
    Frédérique Rodieux, Valérie Piguet, Patricia Berney, Jules Alexandre Desmeules, Marie Jo Besson · 2015 · Personalized Medicine
59. Clinical Pharmacogenetics in Psychiatry
    Bezalel Dantz · 2009 · Psychopharm Review
60. Effects of Caffeine Dose and Administration Method on Time-Trial Performance: A Systematic Review and Network Meta-analysis
    Ruiguo Xue, Jin Huang, Bin Chen, Li Ding, Li Guo, Yinhang Cao, Olivier Girard · 2025 · Research Square
61. Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposure
    Hugo Alarcan, Pauline Cannet, Vincent Camus, Guillaume B. Fond, Xavier Yves Zendjidjian, Romain Guilhaumou, Sylvie Quaranta · 2022 · British Journal of Clinical Pharmacology
62. Measurement of CYP1A2 and CYP3A4 activity by a simplified Geneva cocktail approach in a cohort of free-living individuals: a pilot study
    Constance A. Sobsey, Noor Mady, Vincent R. Richard, Andre M. LeBlanc, Thomas Zakharov, Christoph H. Borchers, Robert Thomas Jagoe · 2024 · Frontiers in Pharmacology
63. Investigation of smoking on the antiplatelet response to clopidogrel: Unravelling the smoker’s paradox
    Frank A. Plakogiannis, Jakob Weidmann, Blake Fraser, Justin Kwong, Diana Asi, Pratham Kumar, Madeleine Baldock, Jasmine Naamo, Ruhani Baluja, Rachelle Louise Cutler et al. · 2024 · Pathology - Research and Practice
64. Sleep, nutrition, and supplements: Implications for athletes
    Jonathan Charest, Michael A. Grandner · 2024 · Elsevier eBooks
65. Effects of CYP1A2 Gene Polymorphisms on Antipyrine CYP1A2-Dependent Metabolism
    Yu. I. Chernyak, Valeria B Itskovich, Sergey Ivanovich Kolesnikov · 2011 · Bulletin of Experimental Biology and Medicine
66. Tobacco Consumption Concerns With the Use of CYP1A2 Metabolized Antidepressants
    Florence Gressier, Samuel Rotenberg, Abd El Kader Ait Tayeb, Romain Colle, Patrick Hardy, Laurent Becquemont, Céline Verstuyft, Emmanuelle Corruble · 2015 · American Journal of Psychiatry
67. Introductory Chapter: Caffeine, a Major Component of Nectar of the Gods and Favourite Beverage of Kings, Popes, Artists and Revolutionists, a Drug or a Poison?
    Magdalena Latosińska, Jolanta Natalia Latosińska · 2017 · InTech eBooks
68. Genetic Influence in Exercise Performance
    Juan Del Coso, Alejandro Lucía · 2021 · Genes
69. 13C-caffeine breath test identifies single nucleotide polymorphisms associated with caffeine metabolism
    Michiko Miyazawa Ishii, Yukimoto Ishii, Tomohiro Nakayama, Yasuo Takahashi, Satoshi Asai · 2020 · Drug Metabolism and Pharmacokinetics
70. Pharmacogenetics in psychiatry
    Falk W. Lohoff · 2012 · Cambridge University Press eBooks
71. Genotype and Phenotype of Caffeine Metabolism: A Biochemistry Laboratory Experiment
    Julie T. Millard, Tenzin Passang, Jiayu Ye, Gabriel M. Kline, Tina M. Beachy, Victoria L. Hepburn, Edmund J. Klinkerch · 2018 · Journal of Chemical Education
72. Drug-Metabolizing Enzymes
    Thomas K. H. Chang · 2009 · Humana Press eBooks
73. The Fundamentals of Second-Language Teaching.
    Jean-Marie LeBlanc · 1997
74. Variable Therapeutic Response in Asthma: A Genetic Perspective
    Pallav Bhatnagar, Randeep Guleria, Ritushree Kukreti · 2006 · Personalized Medicine
75. Coffee and Health
    Gary Williamson · 2011 · Wiley eBooks
76. Metabolic and DNA Repair Variations in Susceptibility to Genotoxins
    Sofia Pavanello · 2003 · Polycyclic aromatic compounds
77. Suplementación Deportiva en Balonmano: Efecto de la Cafeína e Influencia del CYP1A2 y ADORA2A en el Rendimiento Deportivo en Jugadores de Élite de Balonmano
    Alejandro Muñoz Moreno · 2020
78. Activity of cytochrome P450 1A2 in relation to hepatic iron accumulation in transfusion‐dependent β‐thalassaemia major patients
    Shteyer, E., Nitzan, I., Godfarb, A., Hemed, N., Revel‐Vilk, S. · 2015 · Vox Sanguinis
79. Prognostic cardiovascular cut-off values of dietary caffeine in a cohort of unselected men and women from general population
    Valérie Tikhonoff, Edoardo Casiglia · 2023 · Nutrition Metabolism and Cardiovascular Diseases
80. Higher caffeine consumption is associated with insufficient sleep time in Brazilian adults (CUME study)
    Carolynne Martins Teixeira, Josefina Bressan, Arieta Carla Gualandi Leal, Sarah Aparecida Vieira Ribeiro, Leidjaira Lopes Juvanhol, Adriano Marçal Pimenta, Helen Hermana Miranda Hermsdorff · 2023 · International Journal of Food Sciences and Nutrition
81. Influence of the CYP1A2 genotype on the exercise performance of physically active individuals under caffeine supplementation: a systematic review
    Gabriel Peres Messenburger, Fernanda Ferreira Nuñez, Olavo da Silva Carvalho Porepp, Letícia Franco Collares, Felipe Mendes Delpino, Carlos Castilho Barros, Simone Pieniz · 2025 · Nutrition Research
82. No significant effect of caffeine on five kilometer running performance after muscle damage
    Ali M. Al‐Nawaiseh, ROBERT C. PRITCHETT, Kelly L. Pritchett, Mo’ath F. Bataineh, Akef M. Taifour, David Michael Bellar, Makenzie A. Schoeff, Brian D. Fox, Amy Judge, Lawrence W. Judge · 2020 · International Journal for Vitamin and Nutrition Research
83. Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism
    Ruwen Böhm, Henrike Bruckmueller, Stefan Oswald, Matthias Hübenthal, Meike Kaehler, Lena Ehmke, Jan Höcker, Werner Siegmund, André Franke, Ingolf Cascorbi · 2024 · Clinical Pharmacology & Therapeutics
84. Summary of the 2024 Professionals in Nutrition for Exercise and Sport “10 Questions/10 Experts” Session—Hot Topics for the Paris Olympic Games
    Floris C. Wardenaar, Nancy Clark, Trent Stellingwerff, Jason Charles Siegler, Bryan Saunders, Eimear Dolan, Patrick Benjamin Wilson, John Alan Hawley, Cas J. Fuchs, Thorben Aussieker et al. · 2024 · International Journal of Sport Nutrition and Exercise Metabolism
85. Evaluation of pharmacogenomic information in drug labeling: a case study from Jordan
    Yazun Bashir Jarrar, Nancy Hakooz, Mays Abu Ajamieh, Karim Shawagfeh, Rahaf Zaidan, Omar Al Shareef · 2025 · Personalized Medicine
86. Determination of the Distribution of the rs2069514 and rs762551 Alleles of the Cyp1a2 Gene Related to Caffeine Metabolism in Professional Athletes
    Begüm Yücesoy, Sezgin Kapıcı, Canan Sercan, Türkan Yiğitbaşı, Nesrin Emekli, Korkut Ulucan · 2017 · European Journal of Biology
87. The Role of Chemical Carcinogens and Their Biotransformation in Colorectal Cancer
    Loı̈c Le Marchand · 2009 · Springer eBooks
88. Genetic polymorphism analysis of the drug-metabolizing enzyme CYP1A2 in a Uyghur Chinese population: a pilot study
    Tingting Geng, Xi yang Zhang, Li Wang, Huijuan Wang, Xugang Shi, Longli Kang, Peng Hou, Tianbo Jin · 2015 · Xenobiotica
89. No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients
    Pedro Dorado, Roland Berecz, Eva Peñas‐Lledó, Alfredo de la Rubia, Adrián LLerena · 2007 · European Journal of Clinical Pharmacology
90. Expressed sequence tags (ESTs) and single nucleotide polymorphisms (SNPs): What large-scale sequencing projects can tell us about ADME
    Nick J. Plant · 2006 · Xenobiotica
91. Cytochrome P450 Part 2: Genetics of Inter‐Individual Variability
    Michael Ward, Michael Joseph Sorich, Ross Allan McKinnon · 2008 · Journal of Pharmacy Practice and Research
92. Single nucleotide polymorphism of CYP3A4 intron 2 and its influence on CYP3A4 mRNA expression and liver enzymatic activity in human liver
    Min Huang, Hanming Wang, Yu Guo, Jie Ping, Man Chen, Dan Xu, Hui Wang · 2015 · Journal of Huazhong University of Science and Technology [Medical Sciences]
93. Evaluation of the Infertile Female
    Timothy N. Hickman, Rafael A. Cabrera, Laurie Jane McKenzie, Hany F. Moustafa, Botros Rizk · 2008 · Cambridge University Press eBooks
94. Alteration in disposition kinetics of warfarin mediated by caffeine in healthy male albino rabbits.
    Shamaila Zafar, Asghar Ali, M. M. Ashraf, Junaid Ali Khan, Bilal Aslam, Rana Dawood Naseer · 2019 · The Journal of Animal and Plant Sciences
95. The initial and ongoing education of music teachers
    Kate Laurence, Colin Durrant · 2010 · Institute of Education, University of London eBooks
96. Association Between Caffeine Intake and the Plasma Proteome in Humans
    Ouxi Tian, Andrea R. Josse, Christoph H. Borchers, Ahmed El‐Sohemy · 2013 · Journal of Caffeine Research
97. Importance of pharmacogenetic and environmental factors for variation in caffeine disposition: with special emphasis on CYP1A2, CYP2A6, NAT2 and XO
    Nataša Djordjević · 2012 · Figshare
98. Assay for the simultaneous detection of the *1C and *1F alleles of the CYP1A2 gene by real-time polymerase chain reaction and melting curve analysis
    William L. Casley, Carole A. LeBlanc-Westwood · 2006 · Psychiatric Genetics
99. Letter by Palatini Regarding Article, “Habitual Coffee Consumption and Risk of Heart Failure: A Dose-Response Meta-Analysis”
    Paolo Palatini · 2012 · Circulation Heart Failure
100. Variability in Induction of Human Drug Metabolizing Enzymes
     Allan B. Okey · 2005 · Drugs and the pharmaceutical sciences